Benjamin B.

Benjamin B. is an accomplished Principal Scientist at Odyssey Therapeutics since July 2022 and serves as a Venture Partner at Hyperplane Venture Capital, a position held since March 2018. Prior experience includes work in data science at Newco/Inzen/Sonata (Flagship Pioneering) from April 2021 to July 2022, and a Graduate Student Internship at MPM Capital from December 2018 to July 2019. Benjamin's career began at Adnexus Therapeutics (Bristol-Myers Squibb), where tenure lasted from July 2009 to August 2014. Benjamin holds a Doctor of Philosophy (Ph.D.) in Computational and Systems Biology from Boston University School of Medicine and a Bachelor of Arts (A.B.) degree from Dartmouth College.